Events Calendar

There are currently no scheduled events.
News & Information
Mar 18 , 2016
Aquisition of MP Biomedicals by Valiant Co. Ltd

Santa Ana, California, March 18, 2016 – We are pleased to announce MP Biomedicals is now part of the Valiant Family, the acquisition of 100% membership interest of MP Biomedicals was completed on March 18. We appreciate for overall contributions from the former chairman & CEO Mr. Milan Panic and throughout the acquis...

Feb 27 , 2015
Milan Panic to Make Major Donation to City of Hope Cancer Research and Treatment Center

Newport Beach, California, February 27, 2015 – Milan Panic, the founder, president and chief executive officer of MP Biomedicals, LLC, announced today that he will be donating $100,000 to the City of Hope Cancer Research and Treatment Center ahead of its inaugural O...

Feb 25 , 2015
MP Biomedicals, Leading Life Science and Diagnostics Product Provider, Launches New Automated Platform for Nucleic Acid Purification – MPure-12™

Santa Ana, California, February 9, 2015 -- MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, announced today it has launched the MPure-12™ System - an automated platform for the magnetic b...

Dec 11 , 2014
MP Biomedicals Receives First Ever FDA Approval for HTLV Confirmatory Assay

Santa Ana, Calif., December 11, 2014 -- MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products, announced today that it has received FDA approval on the MP Diagnostics HTLV (Human T-Cell Lymphotropic Virus) Blot 2.4, a Western Blot for HTLV confirmatory testing and viral type discrimination. Th...

Apr 04 , 2014
MP Biomedicals, Leading Life Science and Diagnostics Product Provider, Launches New Website
MP Biomedicals, Leading Life Science and Diagnostics Product Provider, Launches New Website

Santa Ana, Calif., April 04, 2014 -- MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, announced today it has launched a new website.

The new website...

Mar 24 , 2014
“Omics” and its Impact on Ensuring Food Safety and Security at the 7th Annual Peptide and Protein Conference, Dalian, China - MP Biomedicals Highlights

Kumar Bala, Head of Global Marketing for MP Biomedicals, LLC, will be a Session Chair and Speaker at the 7th Annual Peptide and Protein Conference at Dalian, China (April 25-28th). His presentation is titled “Omics” and its Impact on Ensuring Food Safety and Security”  will be presented on ...

Dec 05 , 2011
MP Biomedicals Initiates U.S. Clinical Trials for its HTLV Blot 2.4 Confirmatory Test

MP Biomedicals, LLC announced today that the company has begun a clinical trial for the U.S. regulatory approval of MP Diagnostics™ HTLV Blot 2.4 for use in testing serum and plasma in the transfusion and transplantation community. December 05, 2011 the company initiated the clinical data collection phase of the clinical trial, ...

Dec 07 , 2010
MP Biomedicals receives IND approval to commence clinical trials for its HTLV-I/II Screening and Confirmatory tests

Santa Ana, CA December 7, 2010: MP Biomedicals, LLC announced today that it has received approval of its investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to start pivotal clinical trials in the USA with the MP Diagnostics™ HTLV-I/II ELISA 4.0 and HTLV Blot.2.4. Studies will be conducted w...

Jun 14 , 2010
MP Biomedicals Acquires New Zealand Protein Biologics Company
Santa Ana, CA. June 14, 2010: MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland; New Zealand based protein biologics manufacturing company subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and d...
May 13 , 2010
MP Biomedicals to Cooperate with Russian Nanotechnology Corporation in Nanobiotechnology
Santa Ana, CA, May 14, 2010 - MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals...
Mar 09 , 2010
MP Biomedicals Launches World's First Anti-Dengue IgA Rapid Test in Singapor & Online Dengue Information Center (www.mpDengueinfo.com)
Singapore, March 1st 2010 - MP Biomedicals announced the launch of ASSURE® Dengue IgA Rapid Test. This assay is a reverse flow immunochromatographic rapid test for qualitative detection of anti-dengue IgA antibody in human samples (serum, whole blood and plasma) which not only increases the sensitivity of the technique but also make the tes...
Nov 02 , 2009
MP Biomedicals CEO Addresses Students at Peking University, Beijing, China

Milan Panic, the CEO of MP Biomedicals, was invited to speak before hundreds of students at Peking University in Beijing, China on October 23, 2009. His speech titled, "Science Makes Legends", reflected on Mr, Panic's life and achievements. The young people in the audience were encouraged to have dreams and to work at achieving their dreams. Mr....

Oct 29 , 2009
7X Detergent Now Available in Convenient Ready-to-Use Formula
MP Biomedicals announces 7X Ready-to-Use, the newest product in the 7X Detergent line. Researchers have trusted 7X Detergents for over 50 years and now it's ready to use right from the bottle - just pump and go! Perfect for smaller jobs - cleaning labware has never been so easy!

7X Ready-to-Use is available in a 1-gallon bottle ...
Aug 01 , 2009
New products launch on Dengue IgA Rapid Test and Fastsure TB DNA Rapid Test
Rapid tests for dengue virus, tuberculosis launched at AACC...
Jul 27 , 2009
MP Biomedicals Introduces World's First Anti-Dengue IgA Rapid Test
DENGUE is the most rapidly spreading vector-borne disease. An estimated 50 million dengue infections occur annually and approximately 2.5 billion people live in dengue endemic countries (WHO 2008). World Health Organization is concerned with the emergence and re-emergence of dengue as a serious public health threat in dengue endemic countries and g...
Jul 27 , 2009
MP Biomedicals Introduces FASTSURE® TB DNA Rapid Test
Tuberculosis (TB) is a highly contagious and a high social burden disease. Left undiagnosed and untreated, each patient with TB disease may infect on average between 10 and 15 other people every year. According to WHO, someone in the world is newly infected with TB bacilli every second; overall, one-third of the world's population is currently infe...
Jul 13 , 2009
MP Biomedicals Receives Exclusive License for UCLA Alzheimer's Test Technology

UCLA scientists have discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood. Amyloid beta forms the plaques considered the hallmark of Alzheimer's disease, and if the immune system isn't adequately clearing amyloid beta, it may indicate Alzheimer's risk, according to the researchers.

...
Jun 23 , 2009
Isolate Influenza Virus Particles Using FastPrep-24:

The department of Virology of the Erasmus Medical Center in Rotterdam, Netherlands, has successfully optimized the isolation of Influenza A / H3N2 viruses from murine lung tissues by using  the FastPrep-24 instrument.  These astonishing results were published in the peer-reviewed PLoS ONE publication; Bodewes R, Kreijtz JHCM, Baas...

Jun 23 , 2009
MP Biomedicals Exhibits at AACC Clinical Lab Expo, July 19 - 23, 2009

Santa Ana, CA, June 10, 2009 - MP Biomedicals, LLC, a global diagnostics supplier,  will be participating in the upcoming AACC Clinical Lab Expo to be held July 19-23, 2009 at McCormick Place in Chicago. The company's exhibit will feature key products of it's worldwide diagnostic line,  including Western Blot, ELISA...

Apr 20 , 2009
Dr. Miodrag Micic's presents Breaking the Bottleneck in Future Pharmaceuticals Magazine

Breaking the Bottleneck: DR. MIODRAG MICIC, Vice President of Research & Development, MP Biomedicals, talks about his development of the FastPrep-24 line of products for the molecular biology sample preparation of difficult to prepare samples, and shares his views on market trends in drug discovery tools in difficult economic times.

...
Apr 02 , 2009
First large scale cryogenic lysis adapter for FastPrep-24 now available!

MP Biomedicals LLC, manufacturer of the leading sample preparation system, FastPrep-24 has announced the availability of a new cryogenic lysis adapter, TeenCoolPrep. The adapter is designed for cryogenic lysis of medium to large scale RNA preparation from difficult to lyse samples. The adapter is the first cryogenic grinding, homogenization and ...